HC Wainwright & Co. reiterated coverage on Armata Pharmaceuticals with a new price target

3/22/21 6:28:33 AM ET

Biotechnology: Biological Products (No Diagnostic Substances)

Health Care

HC Wainwright & Co. reiterated coverage of Armata Pharmaceuticals with a rating of Buy and set a new price target of $7.00 from $5.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$ARMP

Date	Price Target	Rating	Analyst